Yesterday, March 1, 2016, 87 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $120.60 to $482,600,000.00.

Highlighted Stocks Traded by Insiders:

Evercore Partners (EVR) - FREE Research Report

Sibbald Andrew, who is CEO EVR Partners International at Evercore Partners, sold 19,576 shares at $47.01 on March 1, 2016. Following this transaction, the CEO EVR Partners International owned 285,655 shares meaning that the stake was reduced by 6.41% with the 19,576-share transaction.

The shares most recently traded at $48.88, up $1.87, or 3.82% since the insider transaction. Historical insider transactions for Evercore Partners go as follows:

  • 4-Week # shares sold: 802
  • 12-Week # shares sold: 802
  • 24-Week # shares sold: 802

The average volume for Evercore Partners has been 428,400 shares per day over the past 30 days. Evercore Partners has a market cap of $1.9 billion and is part of the financial sector and financial services industry. Shares are down 9.45% year-to-date as of the close of trading on Tuesday.

Evercore Partners Inc. operates as an independent investment banking advisory firm in the United States, Europe, Latin America, and internationally. The company operates through two segments, Investment Banking and Investment Management. The stock currently has a dividend yield of 2.66%. The company has a P/E ratio of 47.6. Currently, there is 1 analyst who rates Evercore Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EVR - FREE

TheStreet Quant Ratings

rates Evercore Partners as a

buy

. Among the primary strengths of the company is its robust revenue growth -- not just in the most recent periods but in previous quarters as well. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Evercore Partners Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HollyFrontier (HFC) - FREE Research Report

Jennings Michael, who is Executive Chairman at HollyFrontier, sold 100,000 shares at $33.60 on March 1, 2016. Following this transaction, the Executive Chairman owned 212,169 shares meaning that the stake was reduced by 32.03% with the 100,000-share transaction.

The shares most recently traded at $33.10, down $0.50, or 1.52% since the insider transaction. Historical insider transactions for HollyFrontier go as follows:

  • 4-Week # shares sold: 100,000
  • 12-Week # shares sold: 100,000
  • 24-Week # shares bought: 2,200
  • 24-Week # shares sold: 113,161

The average volume for HollyFrontier has been 3.2 million shares per day over the past 30 days. HollyFrontier has a market cap of $6.0 billion and is part of the basic materials sector and energy industry. Shares are down 13.36% year-to-date as of the close of trading on Tuesday.

HollyFrontier Corporation operates as an independent petroleum refiner in the United States. The company operates in two segments, Refining and HEP. The stock currently has a dividend yield of 3.9%. The company has a P/E ratio of 8.7. Currently, there are 5 analysts who rate HollyFrontier a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HFC - FREE

TheStreet Quant Ratings

rates HollyFrontier as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full

HollyFrontier Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Aceto (ACET) - FREE Research Report

Rogers Steven, who is S.V.P. & General Counsel at Aceto, sold 2,100 shares at $21.82 on March 1, 2016. Following this transaction, the S.V.P. & General Counsel owned 15,218 shares meaning that the stake was reduced by 12.13% with the 2,100-share transaction.

The shares most recently traded at $21.88, up $0.06, or 0.29% since the insider transaction. Historical insider transactions for Aceto go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 10,250
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 14,800
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 26,800

The average volume for Aceto has been 249,300 shares per day over the past 30 days. Aceto has a market cap of $633.9 million and is part of the health care sector and drugs industry. Shares are down 18.75% year-to-date as of the close of trading on Tuesday.

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products, and specialty chemicals. The stock currently has a dividend yield of 1.12%. The company has a P/E ratio of 15.9. Currently, there is 1 analyst who rates Aceto a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACET - FREE

TheStreet Quant Ratings

rates Aceto as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Aceto Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.